Abstract: Disclosed are techniques, devices and systems that modify an insulin delivery schedule based on how sensitive a diabetic user may to fluctuations in their total daily insulin or fluctuations in their blood glucose measurement values. As a control algorithm calculates how to adapt the calculation of the user's total daily insulin, a rate of adaptivity function may be used in the calculation. The rate of adaptivity may depend on a number of factors and the disclosed techniques, devices and systems enable calculation of the rate of adaptivity to provide effective implementation or modification of a diabetic treatment plan.

Abstract: A core-shell copolymer, a method of making the same, and a thermoplastic resin composition including the same are disclosed herein. In some embodiments, a core-shell copolymer includes a core and a shell surrounding the core, the core includes a conjugated diene-based monomer-derived repeating unit and a phosphate-based cross-linking agent-derived cross-linking part represented by Formula 1, and the shell includes a first alkyl (meth)acrylate monomer-derived repeating unit, a second alkyl (meth)acrylate monomer-derived repeating unit, and a sulfonate-based ionic monomer-derived repeating unit represented by Formula 2. The core is 68 parts to 92 parts and the shell is 8 parts to 32 parts, based on 100 parts of the core-shell copolymer, the core has a swell index of 2.7 to 10.9, the shell includes 1 wt % to 16 wt % of the sulfonate-based ionic monomer-derived repeating unit, and the shell has a weight average molecular weight of 105,000 g/mol to 645,000 g/mol.

Abstract: Disclosed are techniques to establish initial settings for an automatic insulin delivery device. An adjusted total daily insulin (TDI) factor usable to calculate a TDI dosage may be determined. The adjusted TDI factor may be a TDI per unit of a physical characteristic of the user (e.g., weight) times a reduction factor. The adjusted TDI factor may be compared to a maximum algorithm delivery threshold. Based on the comparison result, the application or algorithm may set a TDI dosage and output a control signal. Blood glucose measurement values may be collected from a sensor over a period of time. A level of glycated hemoglobin of the blood may be determined based on the obtained blood glucose measurement values. In response to the level of glycated hemoglobin, the set TDI dosage may be modified. A subsequent control signal including the modified TDI dosage may be output to actuate delivery of insulin.

Abstract: Disclosed are a device, system, methods and computer-readable medium products that provide techniques to implement functionality to receive blood glucose measurements over a period of time. An average of missing blood glucose measurement values may be maintained over a predetermined time period. A count of a number of missing blood glucose measurement values over a period of time may be established. A controller may calculate a divergence of the number of missing blood glucose measurement values over the period of time from the average of missing blood glucose measurements over the predetermined time period. Based on a value of the divergence, a determination that a safety constraint for delivery of insulin is to be reduced. The safety constraint may be reduced by a predetermined percentage. An instruction to deliver an insulin dosage may be generated according to the reduced safety constraint may be forwarded to a wearable drug delivery device.

Abstract: A semiconductor device includes an active pattern on a substrate, the active pattern extending in a first direction, a gate electrode on the active pattern, the gate electrode extending in a second direction intersecting the first direction and including a first portion and a second portion arranged along the second direction, a first contact plug on the gate electrode, the first contact plug being connected to a top surface of the second portion of the gate electrode, a source/drain region in the active pattern on a sidewall of the gate electrode, and a source/drain contact on the source/drain region, a height of a top surface of the source/drain contact being higher than a top surface of the first portion of the gate electrode and lower than the top surface of the second portion of the gate electrode.

Abstract: The exemplary embodiments provide medicament delivery devices that use cost functions in their control systems to determine medicament dosages. The cost function may have a medicament cost component and a performance cost component. The exemplary embodiments may use cost functions having medicament cost components that scale asymmetrically for different ranges of inputs (i.e., different candidate medicament dosages). The variance in scaling for different input ranges provides added flexibility to tailor the medicament cost component to the user and thus provide better management of medicament delivery to the user and better conformance to a performance target. The exemplary embodiments may use a cost function that has a medicament cost component (such as an insulin cost component) of zero for candidate dosages for a range of candidate dosages (e.g., below a reference dosage).

Abstract: A turbomachine according to an embodiment of the present disclosure may include a rotary shaft, a magnetic bearing including a core body configured to surround the rotary shaft, a plurality of poles radially extending from an inner surface of the core body toward the rotary shaft, and coils wound around the plurality of poles to levitate the rotary shaft by using a magnetic force generated by a magnetic field formed by applied electric current, a sleeve journal bearing disposed between the rotary shaft and the magnetic bearing so as to surround the rotary shaft and configured to levitate the rotary shaft by generating a dynamic pressure when the rotary shaft rotates, and a permanent magnet disposed between the plurality of poles and configured to support the rotary shaft by using a magnetic force.

Abstract: The present invention relates to a three-dimensional oral scanner. In particular, the present invention comprises: a case which can be drawn in and out of an oral cavity and has an opening formed in a manner such that the shape of the inside of the oral cavity (hereinafter, abbreviated as “image”) is introduced to the inside in the form of light through one end thereof; a pair of lenses disposed inside the case and spaced apart from each other in the width direction of the case so as to pass light incident from one end of the case in different paths; a pair of imaging boards having an imaging sensor for imaging the respective lights transmitted through the pair of lenses and disposed in close contact with a widthwise side wall and the other widthwise side wall of the case; and a pair of light path changing units arranged to change the respective paths of the lights transmitted through the pair of lenses toward the imaging board.

Abstract: Disclosed herein is an apparatus for providing golf lessons including: a camera unit configured to photograph images of a golf ball hit by a user with a golf club; a memory configured to store golf lesson data according to ball flight patterns of the golf ball; and a processor for analyzing the images of the golf ball captured by the camera unit to derive the ball flight patterns, reading the golf lesson data according to the ball flight patterns from the memory, and providing the read golf lesson data to the user.

Abstract: Embodiments of the present disclosure relate to a display panel and a method of manufacturing the same. A high-reliability display panel with a reduced bezel area or substantially no bezel area and a method of manufacturing the same.

Abstract: Disclosed are a system, methods and computer-readable medium products that provide safety constraints for an insulin-delivery management program. Various examples provide safety constraints for a control algorithm-based drug delivery system that provides automatic delivery of a drug based on sensor input. Glucose measurement values may be received at regular time intervals from a sensor. A processor may predict future glucose values based on prior glucose measurement values. The safety constraints assist in safe operation of the drug delivery system during various operational scenarios. In some examples, predicted future glucose values may be used to implement safety constraints that mitigate under-delivery or over-delivery of the drug while not overly burdening the user of the drug delivery system and without sacrificing performance of the drug delivery system. Other safety constraints are also disclosed.

Abstract: The present invention relates to a context-based QA generation architecture, and an object of the present invention is to generate diverse QA pairs from a single context. To achieve the object, the present invention includes a latent variable generating network including at least one encoder and an artificial neural network (Multi-Layer Perceptron: MLP) and configured to train the artificial neural network using a first context, a first question, and a first answer, and generate a second question latent variable and a second answer latent variable by applying the trained artificial neural network to a second context, an answer generating network configured to generate a second answer by decoding the second answer latent variable, and a question generating network configured to generate a second question based on a second context and the second answer.

Abstract: Discussed is a display device capable of preventing lowering in a cathode voltage by the provision of an auxiliary connection portion and improving both the transmission efficiency of a transmissive portion and the luminance of an emission portion in a structure having both the transmissive portion and the emission portion.

Abstract: A server includes a communicator and a controller configured to acquire battery status information of each of a plurality of batteries through the communicator, acquire target device information from a user terminal through the communicator, determine a battery from the plurality of batteries having a lifespan corresponding to a required output of a target device among the plurality of batteries as a recommended battery based on the battery status information and the target device information, and control the communicator to transmit information on the recommended battery to the user terminal.

Abstract: Disclosed are a system, methods and computer-readable medium products that provide bolus dosage calculations by a control algorithm-based drug delivery system that provides automatic delivery of a drug, such as insulin or the like, based on sensor input. Blood glucose measurement values may be received at regular time intervals from a sensor. Using the blood glucose measurements, the control algorithm may perform various calculations and determinations to provide an appropriate bolus dosage. The appropriate bolus dosage may be used to respond to a trend in a trajectory of blood glucose measurements. In addition, a bolus dosage may also be determined by the disclosed device, system, method and/or computer-readable medium product in response to an indication that a user consumed a meal.

Abstract: Exemplary embodiments may determine anticipated basal insulin delivery action to a user from an insulin delivery device over a future time window. Indications of the anticipated basal insulin delivery action over the future time window may be output to the user. The exemplary embodiments may determine the anticipated basal insulin delivery action over the future time window based on a rate of change (ROC) of glucose level of the user by the insulin delivery device, a most recent (“current”) glucose level for the user and insulin on board (IOB) for the user. The exemplary embodiments may also determine whether the user is likely to experience a undesired high glucose level (e.g., hyperglycemia) and/or an undesired low glucose level (e.g., hypoglycemia) during the future time window. The exemplary embodiments may output recommendations based on the projected glucose levels of the user over the future time window.

Abstract: Disclosed herein is a method, implemented in an automated drug delivery system for determining a risk of a hypoglycemic or hyperglycemic condition based on risk factors calculated each time a new blood glucose reading is received and providing an alert to the user should a risk be determined. The risk factors may include the current CGM reading, the trend of CGM readings, the amount of insulin-on-board of the user and the accuracy of previous alerts provided to the user. The method may be modified to provide the risk of hypoglycemia if the user were to engage in exercise or other physical activities.

Abstract: Disclosed is a method of manufacturing a cathode for a solid oxide fuel cell (SOFC) including preparing an electrode composition containing urea, ultrasonically spraying the electrode composition onto a GDC scaffold, and drying the scaffold. By using urea, calcination (?700° C.) after each infiltration cycle can be omitted, the next infiltration cycle is performed immediately after the drying (?100° C.), and thus the cathode manufacturing process time can be greatly reduced. Disclosed is also a solid oxide fuel cell including an anode support, an anode functional layer disposed on the anode support, an electrolyte disposed on the anode functional layer, and a cathode disposed on the electrolyte, wherein the cathode is formed by ultrasonic spraying using an electrode composition containing urea.

Abstract: A turbomachine according to an embodiment of the present disclosure may include a rotary shaft, a magnetic bearing including a core body configured to surround the rotary shaft, a plurality of poles radially extending from an inner surface of the core body toward the rotary shaft, and coils wound around the plurality of poles to levitate the rotary shaft by using a magnetic force generated by a magnetic field formed by applied electric current, a sleeve journal bearing disposed between the rotary shaft and the magnetic bearing so as to surround the rotary shaft and configured to levitate the rotary shaft by generating a dynamic pressure when the rotary shaft rotates, and a permanent magnet disposed between the plurality of poles and configured to support the rotary shaft by using a magnetic force.

Abstract: Exemplary embodiments may provide for the switching of glucose prediction models responsive to certain conditions. For example, glucose prediction models may be switched responsive to a detected crashing glucose level condition. Exemplary embodiments also may dynamically customize parameters, such as coefficient values, of the glucose prediction model to a user. The exemplary embodiments may customize the glucose prediction model based on the history of glucose levels of the user and the history of insulin deliveries to the user. The exemplary embodiments may determine a set of parameters that provides an improved fit of the parameters to the history of glucose levels and insulin deliveries of the user. The improved fit parameters may be used to adapt the parameter set to the most recent run.